SEC Charges 8 With Insider Trading in Sanofi (France) Deal

Federal securities regulators charged eight people in Georgia with insider trading on Tuesday, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending deal. The Securities and Exchange Commission said that Thomas D. Melvin Jr., an accountant from Griffin, Ga., learned from a client that the drug giant Sanofi-Aventis was planning to buy Chattem, a pharmaceutical-products company that was then publicly traded. The client, who was a director of Chattem, was seeking Mr. Melvin’s advice on the deal’s tax implications on his stock options and made it clear that the discussion was confidential, the S.E.C. said.

MORE ON THIS TOPIC